Position in INGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$96,846
+$25,659 QoQ
Shares Held
15,015
+30.3% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 129 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INGN Over Time
Shares Held
Position Value (USD)
Derivatives in INGN
reported options exposure · as of Mar 31, 2020CallValue
$464,940
CallShares
9,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $2,666,553,050 across 66 Medical Devices names. INGN ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
19,359,023 | $826,243,101 | |
| 2 | ABT |
Abbott Laboratories
|
8,126,315 | $737,381,823 | |
| 3 | PODD |
Insulet Corp
|
1,903,734 | $289,843,501 | |
| 4 | MDT |
Medtronic plc
|
3,240,847 | $253,531,460 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,521,899 | $137,670,983 | |
| 6 | PEN |
Penumbra Inc
|
428,128 | $135,181,416 | |
| 7 | BRKR |
Bruker Corp
|
200,091 | $45,941,097 | |
| 8 | ESTA |
Establishment Labs Holdings Inc.
|
448,425 | $38,479,349 |
All Filings in INGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,846 | 15,015 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $71,187 | 11,519 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $243,391 | 36,219 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $440,379 | 53,902 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $252,624 | 27,549 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $285,655 | 29,449 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $286,940 | 35,294 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $546,290 | 67,694 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,275,458 | 232,324 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $223,389 | 42,795 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,513,373 | 131,028 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $645,864 | 51,752 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $363,752 | 11,220 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $538,016 | 15,824 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,313,555 | 30,484 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $2,164,821 | 41,219 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $218,932 | 4,900 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,509,377 | 121,013 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,262,238 | 35,536 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,473,083 | 144,659 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $464,940 | 9,000 | Call | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||